The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Hobden Adrian N since year 2005.
The trader's CIK number is 1191076.
At the time of this reporting, Hobden Adrian N is the Pres. Myriad Pharmac of Myriad Pharmaceuticals, Inc. .
(stock ticker symbol MYRX).
See this page for all insider trading activities at Myriad Pharmaceuticals, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2010-04-16 | MYRX | Myriad Pharmaceuticals, Inc. | Option Ex | 28,005 | 1.38 | 38,646 |
| 2010-03-18 | MYRX | Myriad Pharmaceuticals, Inc. | Buy | 20,000 | 4.41 | 88,200 |
| 2010-03-02 | MYRX | Myriad Pharmaceuticals, Inc. | Option Ex | 4,480 | 1.24 | 5,532 |
| 2009-06-08 | MYGN | Myriad Genetics Inc | Option Ex | 37,158 | 11.41 | 423,824 |
| 2009-05-27 | MYGN | Myriad Genetics Inc | Option Ex | 40,000 | 2.39 | 95,600 |
| 2009-05-27 | MYGN | Myriad Genetics Inc | Sale | 40,000 | 34.01 | 1,360,560 |
| 2009-05-08 | MYGN | Myriad Genetics Inc | Option Ex | 17,742 | 5.82 | 103,258 |
| 2008-12-11 | MYGN | Myriad Genetics Inc | Option Ex | 20,000 | 4.78 | 95,620 |
| 2008-12-11 | MYGN | Myriad Genetics Inc | Sale | 20,000 | 60.60 | 1,212,060 |
| 2008-09-29 | MYGN | Myriad Genetics Inc | Option Ex | 21,068 | 5.12 | 107,973 |
| 2008-09-23 | MYGN | Myriad Genetics Inc | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-09-25 | MYGN | Myriad Genetics Inc | Sale | 15,000 | 68.54 | 1,028,130 |
| 2008-09-19 | MYGN | Myriad Genetics Inc | Option Ex | 992 | 5.12 | 5,084 |
| 2008-09-19 | MYGN | Myriad Genetics Inc | Sale | 992 | 66.00 | 65,472 |
| 2008-09-17 | MYGN | Myriad Genetics Inc | Option Ex | 500 | 5.12 | 2,562 |
| 2008-09-18 | MYGN | Myriad Genetics Inc | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-09-17 | MYGN | Myriad Genetics Inc | Sale | 500 | 66.49 | 33,245 |
| 2008-08-25 | MYGN | Myriad Genetics Inc | Option Ex | 27,464 | 5.12 | 140,753 |
| 2008-08-25 | MYGN | Myriad Genetics Inc | Sale | 27,464 | 65.03 | 1,785,928 |
| 2008-03-10 | MYGN | Myriad Genetics Inc | Option Ex | 10,000 | 5.12 | 51,250 |
| 2007-11-30 | MYGN | Myriad Genetics Inc | Option Ex | 5,000 | 5.12 | 25,625 |
| 2007-09-25 | MYGN | Myriad Genetics Inc | Option Ex | 20,000 | 5.12 | 102,500 |
| 2007-09-25 | MYGN | Myriad Genetics Inc | Sale | 20,000 | 50.00 | 1,000,000 |
| 2007-05-23 | MYGN | Myriad Genetics Inc | Sale | 10,000 | 40.00 | 400,000 |
| 2007-05-23 | MYGN | Myriad Genetics Inc | Option Ex | 10,000 | 5.12 | 51,250 |
| 2007-01-03 | MYGN | Myriad Genetics Inc | Option Ex | 5,000 | 5.12 | 25,625 |
| 2007-01-03 | MYGN | Myriad Genetics Inc | Sale | 5,000 | 32.00 | 160,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hobden Adrian N (Pres. Myriad Pharmac of Myriad Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.